Price doesn’t satisfy Congress on appropriations
From the newsletter:
The latest issue of the New England Journal of Medicine is full of eHealth-relevant papers. Two articles consider Scott Gottlieb’s nomination for FDA commissioner. One, by Harvard researcher Daniel Carpenter, argues that Gottlieb is full of deregulatory fervor that will damage the agency’s international credibility. The second, by Harvard economist Amitabh Chandra and Washington University in St. Louis law professor —including, of course, software and other fancy gizmos.
Separately, the journal has a pair of articles on data sharing. The first, proposes the creation of “data authorship” as an incentive for researchers who generate data but don’t necessarily write derivative articles to share their work. The second, focusingon the National Heart, Lung, and Blood Institute data repository, notes that data sharing requests have recently increased.fda health care reform health law policy pharmaceuticals rachel sachs regulation